Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2010
06/01/2010US7728139 for use as latent pigments; photocopiers
06/01/2010US7728135 such as 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine; chemokine receptors (CCR5)
06/01/2010US7728131 Amide derivative and medicine
06/01/2010US7728029 hydroxysteroid reductase inhibitors such as 2'-tert-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid (5-hydroxy-adamantan-2-yl)-amide, used for the treatment of non-insulin dependent diabetes mellitus and metabolic syndrome
06/01/2010US7728025 Glucokinase activators as antidiabetic, antiobesity agents; 5-(4-methanesulfonyl-phenoxy)-2-pyrazin-2-yl-6-(2-carbamoyl-phenoxy)-1H-benzimidazole for example
06/01/2010US7728012 N-(3-Amino-1-benzyl-2,3-dioxopropyl)-2-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}nicotinamide; neurodegenerative disorders, chronic brain supply deficit, ischemia (stroke) o brain trauma, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease
06/01/2010US7728011 Dermally applicable liquid formulations for controlling parasitic insects on animals
06/01/2010US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
06/01/2010US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727996 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
06/01/2010US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/01/2010US7727989 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
06/01/2010US7727988 such as 1-(3-{(1S,5R)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hex-3-yl}propyl)- 2,4(1H,3H)-pyrimidinedione, used in therapy, as modulators of dopamine D3 receptors, to treat drug dependency or as antipsychotic agents
06/01/2010US7727982 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
06/01/2010US7727981 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
06/01/2010US7727690 Iridium complex, carbazole derivatives and copolymer having the same
06/01/2010CA2553915C 3(2h)-pyridazinone compounds as vascular intimal hyperplasia inhibitor
06/01/2010CA2515841C Novel 2-pyridine carboxamide derivatives
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
05/2010
05/27/2010WO2010060074A1 Preparation of nilotinib and intermediates thereof
05/27/2010WO2010059922A1 Pyrrolidine carboxamide compounds
05/27/2010WO2010059773A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
05/27/2010WO2010059611A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059606A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059393A1 Serotonin receptor modulators
05/27/2010WO2010059385A1 Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidne derivatives useful as gdir agonists
05/27/2010WO2010059384A1 Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058409A2 Optical purification of esomeprazole
05/27/2010WO2010058353A1 Novel bis-amides as antimalarial agents
05/27/2010WO2010058314A1 Hydroxyquinolin-2(1h)-ones and derivatives thereof
05/27/2010WO2010058032A2 New compounds
05/27/2010WO2010058030A1 New compounds
05/27/2010WO2010057899A1 Cycloalkyl amino carbonyl derivatives as bradykinin-b1 receptor antagonists
05/27/2010WO2010057418A1 A phenoxypyrimidine derivative, its preparation method and the use thereof
05/27/2010WO2010038081A3 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors
05/27/2010WO2010013222A8 Pyrrole carboxylic acid derivatives as antibacterial agents
05/27/2010WO2009156462A3 Organic compounds
05/27/2010WO2009153178A3 Aryl ketone as mri
05/27/2010US20100130744 Process for the preparation of aripiprazole
05/27/2010US20100130739 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
05/27/2010US20100130738 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
05/27/2010US20100130581 Compounds and methods for the treatment of pain
05/27/2010US20100130560 Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
05/27/2010US20100130558 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers
05/27/2010US20100130557 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
05/27/2010US20100130552 Therapeutic Agents Useful for Treating Pain
05/27/2010US20100130547 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
05/27/2010US20100130545 Bridged six-membered ring compounds
05/27/2010US20100130523 Mono-hydrochloric salts of an inhibitor of histone deacetylase
05/27/2010US20100130522 Compounds for inflammation and immune-related uses
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100130510 Compounds for inflammation and immune-related uses
05/27/2010US20100130509 Novel antibiotics
05/27/2010US20100130505 Compositions and methods for inhibiting g protein signaling
05/27/2010US20100130501 Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h, 6h) carbaldehyde derivatives
05/27/2010US20100130499 Bicycloheteroaryl compounds and their use as trpv1 ligands
05/27/2010US20100130495 Compounds 563
05/27/2010US20100130494 Dermatitis treating agent (as amended)
05/27/2010US20100130486 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/27/2010US20100130485 Cyclopropyl Amines as Modulators of the Histamine H3 Receptor
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/27/2010US20100130471 Renin Inhibitors
05/27/2010US20100130469 2, 6-naphthridine derivatives
05/27/2010US20100130447 Inhibitors of kinase activity
05/27/2010US20100130446 Nitrogen-containing five-membered heterocyclic compound
05/27/2010US20100130359 Fungicidal Pyridazines, Processes for Their Preparation and Their Use for Controlling Harmful Fungi, and Compositions Comprising Them
05/27/2010US20100130358 N-cyanoalkylanthranilamides as insecticides
05/27/2010US20100129320 Quinoline derivatives for modulating dna methylation
05/27/2010CA2744351A1 New compounds
05/27/2010CA2743723A1 Inhibitors of diacylglycerol acyltransferase
05/27/2010CA2743562A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
05/27/2010CA2743497A1 Inhibitors of diacylglycerol acyltransferase
05/27/2010CA2742903A1 Novel bis-amides as antimalarial agents
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/26/2010EP2189456A1 New compounds prepared from omeprazole
05/26/2010EP2189455A1 Process for production of hydrazine compound, intermediate for production of hydrazine compound, and process for production of the intermediate
05/26/2010EP2189454A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
05/26/2010EP2189449A1 Aminopyrazole amide derivative
05/26/2010EP2189447A1 Enantioselective alkylation of tricyclic compounds
05/26/2010EP2188275A2 Novel preparation process
05/26/2010EP2188274A1 Viral polymerase inhibitors
05/26/2010EP2188268A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
05/26/2010EP2188266A2 Novel piperazine amide derivatives
05/26/2010EP2188263A1 Benzimidazole derivatives used as fxr agonists
05/26/2010EP2188260A1 Therapeutic quinoline and naphthalene derivatives
05/26/2010EP2188258A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products
05/26/2010EP2188255A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
05/26/2010EP2188253A2 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
05/26/2010EP2079724B1 Substituted pyridone compounds and methods of use
05/26/2010EP2051976B1 4-[5-methoxy-6-(2-methyl-6-[1,2,4]triazol-1-yl-pyridin-3-ylamino)-pyrimidin-4-yloxy]-piperidine-1-carboxylc acid isopropyl ester as modulator of metabolism and the treatment of disorders related thereto
05/26/2010EP1874739B1 Pharmaceutically active diazepanes
05/26/2010EP1651613B1 4,5-dihydro-imidazole as p2x7 ion channel blockers
05/26/2010EP1622881B1 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect
05/26/2010EP1585727B1 Indoles useful in the treatment of androgen-receptor related diseases
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 1080